Recent News

522 News Items found
In the News
Pictured: Jedd Wolchok and James Allison
The New Yorker Features Immune Therapy Work of Memorial Sloan Kettering Researchers
In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute's Immunology Program, and medical oncologist and immunologist Jedd Wolchok.
Profile
Pictured: Michael Kharas
An Interview with Cancer Biologist Michael Kharas
As a child, Michael Kharas knew that he wanted to “be making the drugs doctors use to cure people.” Today he investigates molecular processes that stem cells and tumor cells have in common – in the hopes of uncovering insights for treatments for cancer and other diseases.
In the Lab
Pictured: T cells on surface on thymus
Study Points the Way for Future Therapy to Revive a Damaged Immune System
A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.
Honors
Pictured: Charles Sawyers
Charles Sawyers Elected President of the American Association for Cancer Research
Beginning in April 2013, physician-scientist Charles Sawyers will serve as President of the American Association for Cancer Research, the world’s oldest and largest professional organization dedicated to advancing cancer research.
Pictured: Ping Chi
Ping Chi Named to Geoffrey Beene Junior Faculty Chair
Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers.
Pictured: David Solit
Study Reveals How Some Skin Tumors May Evade New Therapy
Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.
In the Lab
Pictured: Timothy Chan
Studies Show How Certain Gene Mutations May Promote Cancer
Two Memorial Sloan Kettering studies provide new clues about genetic mutations that affect cell behavior and play a role in several types of cancer.
Q&A
Pictured: Ion Channel K2P1
3D Shape of an Ion Channel Revealed
Structural biologist Stephen Long talks about how his team used x-ray crystallography to discover the structure of an ion channel called K2P1.
Pictured: Craig Thompson
Craig Thompson Named President of Memorial Sloan Kettering
Nationally known cancer researcher and clinician Craig B. Thompson was named the new President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center in August 2010. He also becomes President of Gerstner Sloan Kettering Graduate School of Biomedical Sciences.
In the Lab
Pictured: Structural formula of IBNtxA
Findings Could Lead to the Development of a New Painkiller
Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.